Ovarian function after COVID-19: long-term effects and vaccine safety in ART patients
Journal of Assisted Reproduction and Genetics,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 30, 2025
Язык: Английский
COVID-19 and Female Fertility: An Observational Prospective Multicenter Cohort Study: Upholding Reproductive Rights in Emergency Circumstances
Diagnostics,
Год журнала:
2024,
Номер
14(19), С. 2118 - 2118
Опубликована: Сен. 24, 2024
Objectives:
Currently
available
research
data
points
to
COVID-19-related
multi-organ
system
damage.
This
study
aims
evaluate
the
impact
of
SARS-CoV-2
on
reproductive
health,
that
is,
plasma
levels
FSH,
LH,
estradiol,
AMH,
and
antral
follicular
count,
women
undergoing
level
II
ART
techniques.
Methods:
is
a
multicenter,
prospective,
observational
by
medicine
centers
Palermo’s
Ospedali
Riuniti
Villa
Sofia-Cervello
Hospital
Vanvitelli
University.
From
September
2022
March
2024,
203
patients
aged
24–43
were
enrolled,
all
with
diagnosed
infertility
history
infection.
Symptomatic
women,
testing
positive
for
HIV
or
other
liver
viruses,
ovarian
cancer
who
had
taken
gonadotoxic
drugs
excluded.
Plasma
measurements
count
performed
before
after
Results:
The
analysis
accounting
concentration
anti-Müllerian
hormone
(AMH)
COVID-19
infection
shows
an
average
decrease
from
1.33
ng/mL
0.97
Average
was
−27.4%;
reduction
1
follicle
(95%
CI:
−0.74
−1.33)
reported
following
Levels
E2
did
not
vary
significantly.
FSH
LH
pointed
increase.
Conclusions:
damages
female
causing
significant
reductions
in
AMH
(−27.4%)
AFC
(−1
follicle)
values
increase
(+13.6%)
(+13.4%)
values.
No
effect
reported.
pandemic
has
also
affected
ability
infertile
access
procedures,
calls
novel,
updated
blueprint
designed
enhance
our
preparedness
event
similar
circumstances
should
occur
again.
Язык: Английский
Effect of the Covid Pandemic on Women’s Health
Monica DeMasi,
Laura Bujold
Primary Care Clinics in Office Practice,
Год журнала:
2025,
Номер
52(2), С. 371 - 382
Опубликована: Апрель 6, 2025
Язык: Английский
Long-Term Effects of COVID-19 on Women’s Reproductive Health and Its Association with Autoimmune Diseases, Including Multiple Sclerosis
Journal of Clinical Medicine,
Год журнала:
2025,
Номер
14(9), С. 3057 - 3057
Опубликована: Апрель 29, 2025
Concern
over
COVID-19's
long-term
influence
on
women's
reproductive
health
is
growing,
with
emerging
research
suggesting
potential
links
to
ovarian
dysfunction,
menstrual
irregularities,
fertility
challenges,
and
adverse
pregnancy
outcomes.
Post-viral
immune
dysregulation
linked
both
the
development
exacerbation
of
autoimmune
diseases,
including
multiple
sclerosis
(MS).
Long
COVID
has
been
associated
immunological
hormonal
imbalances,
chronic
inflammation,
all
which
may
worsen
disorders
issues.
characterized
by
symptoms
persisting
for
weeks
or
months
beyond
acute
infection
phase.
There
are
indications
that
prolonged
contribute
disease
through
mechanisms
such
as
hyperactivation,
molecular
mimicry,
dysregulated
cytokine
responses.
Although
this
field
still
emerging,
growing
evidence
suggests
SARS-CoV-2
have
lasting
effects
health,
highlighting
need
further
studies
into
its
underlying
clinical
This
review
compiles
recent
findings
impact
COVID-19
association
disorders,
particularly
MS.
Язык: Английский
Long COVID and endometriosis: a systematic review and meta-analysis
BMC Women s Health,
Год журнала:
2025,
Номер
25(1)
Опубликована: Май 15, 2025
Язык: Английский
Changes in female cancer diagnostic billing rates over the COVID-19 period in the Ontario Health Insurance Plan
Therapeutic Advances in Medical Oncology,
Год журнала:
2025,
Номер
17
Опубликована: Май 1, 2025
Background:
The
initial
response
to
coronavirus
disease
2019
(COVID-19)
in
Ontario
included
suspension
of
cancer
screening
programs
and
deferral
diagnostic
procedures
many
treatments.
Although
the
short-term
impact
these
measures
on
female
cancers
is
well
documented,
few
studies
have
assessed
mid-
long-term
impacts.
Objectives:
To
compare
annual
billing
prevalence
incidence
rates
during
COVID-19
period
(2020–2022)
pre-COVID-19
levels
(2015–2019).
Design:
Retrospective
analysis
aggregated
claims
data
for
codes
from
Health
Insurance
Plan
(OHIP).
Methods:
Linear
regression
was
used
fit
(2015–2019)
each
OHIP
code
extrapolate
counterfactual
values
years
2020–2022.
Excess
were
calculated
as
difference
between
projected
actual
year.
Results:
In
2020,
cervical,
breast,
uterine,
ovarian
decreased
relative
that
year
by
−50.7/100k,
−13.9/100k,
−3.5/100k,
−3.8/100k,
respectively.
reverse
observed
2021
with
rate
increases
47.8/100k,
59.1/100k,
2.5/100k,
3.7/100k,
2022,
excesses
further
amplified,
especially
cervical
breast
(111.2/100k
78.67/100k,
respectively).
net
excess
patient
2020–2022
largely
positive
all
types
(108.3/100k,
123.7/100k,
5.2/100k,
1.8/100k,
Analysis
showed
similar
trends.
Conclusion:
expected
decreases
2020
followed
large
resulting
a
cumulative
period.
Further
research
required
assess
nature
changes.
Язык: Английский
The Influence of Long COVID on the Cardiovascular System and Predictors of Long COVID in Females: Data from the Polish Long COVID Cardiovascular (PoLoCOV-CVD) Study
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(24), С. 7829 - 7829
Опубликована: Дек. 22, 2024
Background/Objectives:
Female
sex
is
one
of
the
Long
COVID
(LC)
risk
factors;
however,
LC
predictors
in
females
have
not
been
established.
This
study
was
conducted
to
assess
influence
on
cardiovascular
system
and
age-independent
females.
Methods:
Patient
information
course
disease
with
symptoms
were
collected
women
at
least
12
weeks
after
COVID-19
recovery.
The
participants
followed
for
months.
ECG
monitoring,
24
h
blood
pressure
echocardiography,
biochemical
tests
performed.
Results:
We
studied
1946
consecutive
female
patients
(age
53.0
[43.0–63.0]
vs.
52.5
[41.0–63.0],
p
=
0.25).
A
more
frequent
occurrence
observed
a
severe
SARS-CoV-2
infection
(p
0.0001).
Women
compared
control
group
had
higher
body
mass
index
0.001),
lower
level
HDL
cholesterol
0.015),
TG
<
0.001)
TG/HDL
ratio
often
myocardial
damage
LVEF
0.01).
QRS
fragmentation,
longer
QTcB,
abnormalities.
In
multivariate
analysis
younger
BMI
>
24.8
kg/m2,
1.89
older
females,
1.89,
LVEF,
also
independent
predictors.
Conclusions:
Independent
women,
regardless
age,
are
1.89.
presence
comorbidities
lifestyle
before
no
impact
age.
Язык: Английский